CDT

CDT
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $6.148M ▲ | $-7.118M ▼ | 0% | $4.05 ▲ | $-6.282M ▼ |
| Q2-2025 | $0 | $4.952M ▲ | $-6.028M ▼ | 0% | $1.54 ▲ | $-5.143M ▼ |
| Q1-2025 | $0 | $3.616M ▲ | $-4.753M ▼ | 0% | $-1.32 ▼ | $-4.38M ▼ |
| Q4-2024 | $0 | $3.061M ▼ | $-2.406M ▲ | 0% | $3.88 ▲ | $-994K ▲ |
| Q3-2024 | $0 | $5.806M | $-6.461M | 0% | $1.32 | $-6.146M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $4.828M ▲ | $8.552M ▲ | $4.274M ▼ | $4.278M ▲ |
| Q2-2025 | $3.332M ▲ | $7.989M ▲ | $4.46M ▼ | $3.529M ▲ |
| Q1-2025 | $2.13M ▼ | $7.321M ▲ | $4.634M ▼ | $2.687M ▲ |
| Q4-2024 | $370.302M ▲ | $4.193M ▲ | $10.986M ▼ | $-6.793M ▲ |
| Q3-2024 | $152K | $2.993M | $12.111M | $-9.118M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.69M ▲ | $105.006M ▲ | $-39.802M ▼ | $-54.164M ▼ | $12.771M ▲ | $65.325M ▲ |
| Q2-2025 | $-6.028M ▼ | $-2.58M ▼ | $-1K ▲ | $3.757M ▲ | $1.202M ▲ | $-2.581M ▲ |
| Q1-2025 | $51.937M ▲ | $7.441M ▲ | $-24.178M ▼ | $-96.784M ▼ | $-111.305M ▼ | $-24.761M ▼ |
| Q4-2024 | $-2.406M ▲ | $-3.813M ▼ | $85K ▼ | $4.21M ▲ | $483K ▲ | $-3.813M ▼ |
| Q3-2024 | $-6.461M | $-1.999M | $96K | $1.744M | $-148K | $-2.04M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
Automation Solutions | $350.00M ▲ | $370.00M ▲ | $380.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Putting it all together, CDT appears to be a tiny, research‑driven vehicle with minimal revenue, ongoing losses, and a very weak standalone balance sheet. Its main strength lies in specialized intellectual property and a legacy of innovation in advanced display and materials technologies, potentially reinforced by connections to a much larger industrial parent. The main risks center on funding, dilution, execution, and the long and uncertain path from lab work to commercial adoption. Anyone tracking CDT would likely focus on two things: whether it can secure stable financing, and whether its technology and partnerships can translate into recurring, scalable revenue rather than remaining primarily a research story. There is also some structural complexity, as the qualitative description refers to a subsidiary role within a larger group, so understanding exactly how value flows to this listed entity would be important.
NEWS
November 28, 2025 · 9:04 AM UTC
CDT Environmental Technology Announces Results of Annual General Meeting
Read more
November 28, 2025 · 9:00 AM UTC
CDT Environmental Technology Announces Results of Annual General Meeting
Read more
November 20, 2025 · 8:36 AM UTC
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
Read more
November 20, 2025 · 8:30 AM UTC
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
Read more
October 17, 2025 · 8:30 AM UTC
CDT Equity Increases Bitcoin Holding
Read more
About CDT Equity Inc.
https://www.conduitpharma.comCDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $6.148M ▲ | $-7.118M ▼ | 0% | $4.05 ▲ | $-6.282M ▼ |
| Q2-2025 | $0 | $4.952M ▲ | $-6.028M ▼ | 0% | $1.54 ▲ | $-5.143M ▼ |
| Q1-2025 | $0 | $3.616M ▲ | $-4.753M ▼ | 0% | $-1.32 ▼ | $-4.38M ▼ |
| Q4-2024 | $0 | $3.061M ▼ | $-2.406M ▲ | 0% | $3.88 ▲ | $-994K ▲ |
| Q3-2024 | $0 | $5.806M | $-6.461M | 0% | $1.32 | $-6.146M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $4.828M ▲ | $8.552M ▲ | $4.274M ▼ | $4.278M ▲ |
| Q2-2025 | $3.332M ▲ | $7.989M ▲ | $4.46M ▼ | $3.529M ▲ |
| Q1-2025 | $2.13M ▼ | $7.321M ▲ | $4.634M ▼ | $2.687M ▲ |
| Q4-2024 | $370.302M ▲ | $4.193M ▲ | $10.986M ▼ | $-6.793M ▲ |
| Q3-2024 | $152K | $2.993M | $12.111M | $-9.118M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.69M ▲ | $105.006M ▲ | $-39.802M ▼ | $-54.164M ▼ | $12.771M ▲ | $65.325M ▲ |
| Q2-2025 | $-6.028M ▼ | $-2.58M ▼ | $-1K ▲ | $3.757M ▲ | $1.202M ▲ | $-2.581M ▲ |
| Q1-2025 | $51.937M ▲ | $7.441M ▲ | $-24.178M ▼ | $-96.784M ▼ | $-111.305M ▼ | $-24.761M ▼ |
| Q4-2024 | $-2.406M ▲ | $-3.813M ▼ | $85K ▼ | $4.21M ▲ | $483K ▲ | $-3.813M ▼ |
| Q3-2024 | $-6.461M | $-1.999M | $96K | $1.744M | $-148K | $-2.04M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
Automation Solutions | $350.00M ▲ | $370.00M ▲ | $380.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Putting it all together, CDT appears to be a tiny, research‑driven vehicle with minimal revenue, ongoing losses, and a very weak standalone balance sheet. Its main strength lies in specialized intellectual property and a legacy of innovation in advanced display and materials technologies, potentially reinforced by connections to a much larger industrial parent. The main risks center on funding, dilution, execution, and the long and uncertain path from lab work to commercial adoption. Anyone tracking CDT would likely focus on two things: whether it can secure stable financing, and whether its technology and partnerships can translate into recurring, scalable revenue rather than remaining primarily a research story. There is also some structural complexity, as the qualitative description refers to a subsidiary role within a larger group, so understanding exactly how value flows to this listed entity would be important.
NEWS
November 28, 2025 · 9:04 AM UTC
CDT Environmental Technology Announces Results of Annual General Meeting
Read more
November 28, 2025 · 9:00 AM UTC
CDT Environmental Technology Announces Results of Annual General Meeting
Read more
November 20, 2025 · 8:36 AM UTC
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
Read more
November 20, 2025 · 8:30 AM UTC
CDT Environmental Technology Announces New Strategic Growth Initiatives, Enters Clean Energy Market with Waste-to-Hydrogen Technology
Read more
October 17, 2025 · 8:30 AM UTC
CDT Equity Increases Bitcoin Holding
Read more

CEO
James Bligh
Compensation Summary
(Year 2024)

CEO
James Bligh
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-10-13 | Reverse | 1:8 |
| 2025-05-20 | Reverse | 1:15 |
| 2025-01-27 | Reverse | 1:100 |
Ratings Snapshot
Rating : A-
Institutional Ownership
Summary
Only Showing The Top 1


